These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1354398

  • 1. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY, Asdourian D, Chiodo LA.
    Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398
    [Abstract] [Full Text] [Related]

  • 2. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Aug; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 3. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 4. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD, Freeman AS, LeWitt PA, Chiodo LA.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
    [Abstract] [Full Text] [Related]

  • 5. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 6. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC, Maslowski-Cobuzzi RJ.
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [Abstract] [Full Text] [Related]

  • 8. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
    Hu XT, Wang RY.
    J Neurosci; 1988 Nov; 8(11):4340-8. PubMed ID: 2972814
    [Abstract] [Full Text] [Related]

  • 9. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
    Napier TC.
    Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
    [Abstract] [Full Text] [Related]

  • 10. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 12. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH, Kasser RJ, Altar CA, Wang RY.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
    [Abstract] [Full Text] [Related]

  • 13. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH, Bergstrom DA, Weick BG, Walters JR.
    Synapse; 1987 Jun; 1(5):411-6. PubMed ID: 2975067
    [Abstract] [Full Text] [Related]

  • 14. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN, Bergstrom DA, Walters JR.
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P, Mercuri NB, Sancesario G, Bernardi G.
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
    Moody CA, Spear LP.
    Psychopharmacology (Berl); 1992 Apr; 107(1):39-49. PubMed ID: 1350350
    [Abstract] [Full Text] [Related]

  • 17. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1988 Apr; 2(4):416-23. PubMed ID: 2973142
    [Abstract] [Full Text] [Related]

  • 18. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD, Freeman AS, Chiodo LA.
    Synapse; 1989 Apr; 3(1):30-7. PubMed ID: 2919369
    [Abstract] [Full Text] [Related]

  • 19. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
    Heidenreich BA, Mailman RB, Nichols DE, Napier TC.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):516-25. PubMed ID: 7714807
    [Abstract] [Full Text] [Related]

  • 20. Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors.
    Widzowski DV, Cory-Slechta DA.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):526-34. PubMed ID: 8355188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.